Sponsor:
Icahn School of Medicine at Mount Sinai
Code:
NCT05873218
Conditions
Labor
Eligibility Criteria
Sex: Female
Age: 18 - 55
Healthy Volunteers: Accepted
Interventions
Ephedrine
Normal Saline Placebo
Brief summary:
Conditions
Labor
Study ID
NCT05873218
Start date
Jun 26, 2023
Status verified date
May, 2026
Completion date
May, 2027
Anticipated
Primary completion date
May, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 55
Healthy Volunteers: Accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Sequential
Primary purpose
Prevention
Arms
experimental: Ephedrine
placebo comparator: Placebo
Interventions
Ephedrine
Normal Saline Placebo
Primary outcome measure
Central contacts
Locations
Icahn School of Medicine at Mount SInai
Recruiting
New York, New York, United States, 10029
Contacts
Daniel Katz, MD
daniel.Katz@montsinai.orgPrincipal Investigator:
Daniel Katz
Sponsor
Icahn School of Medicine at Mount Sinai
Last update posted
May 6, 2026
Last verified
May, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2026-05-06.